The company is a listed enterprise focusing on research and product development on comprehensive utilization of gypsum resources, and integrates diverse industries such as pharmaceuticals. The stock is abbreviated as “Sansheng Co., Ltd.” From focusing on the development of gypsum resources, to establishing a circular economy business chain for the collaborative development of integrated products such as expansion agents, water reducing agents, commercial concrete, sulfuric acid, etc., to using capital operations to explore the pharmaceutical manufacturing field, Sansheng Co., Ltd. has established a joint stock enterprise structure with complete industrial chain integration. Currently, the company has 20 wholly-owned subsidiaries or branches (factories), covering six major fields of commercial concrete, concrete admixtures, chemicals, mining, pharmaceuticals, and investment. The company currently has two major business segments: building materials chemicals and pharmaceutical manufacturing. Main products: commercial concrete, water reducing agents, leavening agents, sulfuric acid, pharmaceutical intermediates, APIs and pharmaceutical products, etc. Honors include well-known trademarks in China, high-tech enterprises, and Chongqing Concrete Admixture Engineering Technology Research Center.
No Data